DCIS Breast Cancer Tissue Microarray (32 cases) – MBB5

Our DCIS Breast Cancer Tissue Microarray – MBB5 comes in 2 variations:

  1. MBB5:
    • 32 cases/35 cores: DCIS tissue array, including TNM and pathology diagnosis
    • Core diameter: 0.6mm
    • Thickness: 4μm
  2. MBB5a:
    • 32 cases/35 cores: DCIS tissue array, including TNM, pathology diagnosis, and IHC markers
    • Core diameter: 0.6mm
    • Thickness: 4μm

WhatsApp Us or fill in the Contact Us form to get a quote for DCIS Breast Cancer Tissue Microarray – MBB5.

Breast Cancer Tissue Microarray for Cancer Research

Tissue microarrays (TMAs) are high-efficiency research tools that embed multiple tissue samples into a single paraffin block, allowing researchers to analyze large cohorts under uniform experimental conditions. A breast cancer tissue microarray enables the investigation of tumour biology across various subtypes such as luminal A/B, HER2-enriched, and triple-negative breast cancers. It supports the identification of prognostic and predictive biomarkers, evaluation of tumour heterogeneity, and development of targeted therapies—all using a cost-effective, standardized format.

Breast cancer TMAs are most commonly used in immunohistochemistry (IHC) and hematoxylin and eosin (H&E) staining. IHC is essential for detecting markers such as estrogen receptor (ER), progesterone receptor (PR), HER2, and Ki-67, which are critical for subtype classification and treatment planning. H&E staining offers a clear view of tissue architecture, cell morphology, and tumour grading. Together, these methods provide comprehensive insights into tumour pathology, making TMAs indispensable in both basic research and translational oncology.

Role of Tissue Microarrays in TME Research

Tissue microarrays have transformed how researchers explore the tumour microenvironment (TME). They enable high-throughput analysis of multiple tissue samples simultaneously, making them essential for identifying biomarkers, conducting immune profiling, and performing spatial analysis. TMAs allow researchers to map immune cell infiltration, tumour heterogeneity, and stromal interactions across a broad cohort. Because human-derived TMAs preserve spatial organization, they provide a more accurate representation of the TME compared to animal models. This accelerates the validation of predictive biomarkers and improves the understanding of therapy response, ultimately pushing forward the development of personalised cancer treatment strategies.

Why Choose MYmAb Biologics' Tissue Microarray Over Others

What sets MYmAb Biologics apart is more than just technical quality. It’s the depth and relevance of our source material:

We also offer services such as:

Staining Services

High quality H&E and IHC staining services with fast turnaround time and competitive pricing.

IHC Staining Training

Comprehensive 2-day staining training workshop with certification of completion.

Scanning & Storage Services

Scanning service that allows researchers to view slides on the monitor and storing of virtual slides.

Contact Our Team

Location:
Block D-G-8, UPM-MTDC Technology Centre III, Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia.

Phone:
03-8938 9819

Email:
info.mymab@gmail.com

Contact us form
Product code

MBB5

Cases

32

Row number

6

Column number

8

Core diameter (mm)

0.6

Thickness

4μm

Tissue array type

FFPE

Species

Human

Application

– Immunohistochemistry
– In situ hybridization
– Fluorescent in situ hybridization
– Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) analysis
– In situ polymerase chain reaction (in situ PCR)

Notes

– Storage temperature: 4°C
– Shipping temperature: Ambient